# Journey Colab

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/journey-colab

- Industry: Pharmaceuticals
- Headquarters: San Francisco, US
- Website: www.journeycolab.com
- Total disclosed funding: $12M
- Latest round: Series A (Sep 7, 2021)
- Investors on record: 5

## About

Based in California, US, and founded in 2020, Journey Colab Corp. operates as a  psychedelic pharmaceutical startup company that was founded by its current CEO Jeeshan Chowdhury. In September 2021, the company raised USD 12 million in series A funding from new investors MBX Capital, Delphi VC, Uprising, Lionheart Ventures, Apollo Projects, and individual investors.

The company develops a pipeline of psychedelic treatments used for the treatment of mental health-related problems of individuals and strengthens communities.

As part of the series A funding in September 2021, Journey Colab Corp. will be able to fund its plan to accelerate the development of its psychedelic compounds. The company also plans to initiate its Phase 1 study of JOUR-001 for AUD in 2022.

## Funding rounds

- Series A, Sep 7, 2021, $12M — Uprising, MBX Capital, Lionheart Ventures, Delphi VC, Apollo Projects

## Investors

- Uprising (https://capitalatlas.ai/funds/uprising) — Series A
- MBX Capital (https://capitalatlas.ai/funds/mbx-capital) — Series A
- Lionheart Ventures (https://capitalatlas.ai/funds/lionheart-ventures) — Series A
- Delphi VC (https://capitalatlas.ai/funds/delphi-vc) — Series A
- Apollo Projects (https://capitalatlas.ai/funds/apollo-projects) — Series A